Healthcare Leaders Income ETF (HHL.TO) Buy,…

Home

Daily Stock Opinions and Ratings

Healthcare Leaders Income ETF (HHL.TO)

7.06

-0.08 (1.12%)

as of Jun 30, 2026, 7:56:05 pm Market Open.

232 watching

Investor Insights

Jun 30, 2026, 12:00 am

This summary was created by AI, based on 5 opinions in the last 12 months.

The Healthcare Leaders Income ETF (HHL-T) faces a challenging environment due to pressure on the US healthcare sector, notably from health insurance companies and policies affecting pharma costs. It maintains a diversified portfolio with roughly 20-23 large global healthcare names, focusing on pharmaceuticals (35%), healthcare equipment (25%), and biotech (14%). Experts recommend HHL for its balance of income generation and potential growth, especially when paired with ETFs like XHC for additional growth. Although the sector has been volatile and affected by political factors, some analysts believe the negativity surrounding it might be overdone, and recent inflows into the ETF suggest a rebound could be on the horizon. The demographic trends could further support a recovery as clarity emerges in the US healthcare landscape.

Consensus

Positive

Valuation

Fair Value

Similar

ABBV

BUY

His firm manages this. Contains 20 large cap healthcare companies, with a covered call strategy. Good for monthly cashflow. If you want more beta, there are other alternatives. Over the last year, large cap has absolutely dominated small caps, and he doesn't see this abating this year. Yield north of 8%.

BUY ON WEAKNESS

Late in the cycle, healthcare tends to outperform and is less sensitive to volatility. If the broad markets pull back, he would wait for the uncertainty to be priced in more.

BUY

Harvest has many covered call ETFs, using 25-30% of the stocks within an ETF that is a covered call. If you want yield, these look attractive, all the Harvest ETFs. But he's not 100% certain how they work, but has never heard of any problems. Generally, this is good.

BUY

Healthcare is a great area that is robust to growth shocks. The yield is also enhanced by the covered call writing. A good compliment for Canadians to diversify. Has a place in a portfolio.

BUY

For income in retirement account. Would prefer ZWU to HHL. If markets correct over the next few quarters, there will be more correction in HHL. Likes both and are both buys in pull backs.

BUY

For income in retirement account. Would prefer ZWU to HHL. If markets correct over the next few quarters, there will be more correction in HHL. Likes both and are both buys in pull backs.

BUY

HHL-T & XHC-T. HHL-T has a high yield because they do covered calls. He prefers the XHC-T ETF for slightly more yield. HHL-T is a viable option but you are capping the upside.

BUY

Overall, as society ages, healthcare will become a more important part. The cost of healthcare will cause government pushback on big pharma. It is a growth area. Healthcare technology will be a big part of growth. There is the underlying dividends and covered calls.

COMMENT

Comment on the change from ROC to capital gains on fund distribution. Bulk of distribution is generated through covered calls, which are taxed as capital gains. Still a tax efficient distribution. HHL.A is currency hedged, while the HHL.U is priced in US dollars.

COMMENT

They use a covered call strategy to enhance the yield. Those who want exposure to healthcare space but want higher yield, it is a good option. If yield is not a concern for you, you're better off with ZUH.

BUY

A broad based actively managed healthcare company fund. They screen fundamentally for better names in the healthcare space with covered calls for extra yield. A good yield play with less market volatility.

BUY

Disclosure: He runs this ETF, 20 equally-weighted large US healthcare stocks. He makes minor adjustments periodically, like selling Gilead recently. He wants diversification across this space. Pays a high dividend, using covered calls for a third of the holdings. This is good if you want US healthcare and regular income with some appreciation.

BUY

A managed strategy that is designed to produce high yield through options and other strategy. There are elements of growth but the price has stayed consistent. The dividend has stayed north of 7%. You're investing for the yield and to get exposure to healthcare.

COMMENT

Attractive income, equal weighted 20 largest healthcare companies. Covered calls on a portion of the portfolio. Secularly, has some solid fundamentals of increased spending in drug sales and healthcare. Suspects the 9% yield is not sustainable with low interest rates.

COMMENT

These are some of the best ETFs for playing healthcare depending on what strategy you like. These cover global, covered call, yield focused, or actively managed ETFs in the market. The sector is a little overvalued right now so you might want to wait for a pullback. Longterm outlook is favourable.

Showing 31 to 45 of 89 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Bruce Murray

The Murray Wealth Group

Joe Terranova

Virtus Investment Partners

Stephanie Link, Chief investment strategist, Hightower

Hightower

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Healthcare Leaders Income ETF (HHL.TO)